186 Re-Cefixime such as the amount of Cefixime and stannous chloride, pH, reaction time and reaction temperature were studied to optimize the labeling conditions to obtain the highest radiochemical yield of 186 Re-Cefixime. The radiochemical purity of Rhenium-186 was determined by paper chromatography, while the radiochemical yield and purity of 186 Re-Cefixime were determined by electrophoresis and high-performance liquid chromatography (HPLC). The maximum radiochemical yield of 186 ReCefixime was obtained (96±2.8%) using 2mg Cefixime, 0.3mg carrier added 186 Re and 0.5mg stannous chloride at pH 5.5, within 30min at room temperature. The bio-distribution was carried out on three types of mice (normal, sterile infected and bacterial infected). The results show that
Introduction
Physiological imaging of bacterial infection is the advantage that favors the nuclear medicine technique to determine the bacterially infected areas (Boerman et al., 2006) . The radioactive nuclides labelled with biomolecules, evaluating their distribution in human bodies by SPECT or PET system, which is based on the decay mode of radionuclide (γ-or β + -emissions), for example,
67
Ga-citrate as a SPECT imaging or 18 FDG as a PET imaging are used to depict inflammations. Several radiolabeled agents bind in vivo specifically to bacterial cells have been developed, such as a complex of 99m Tc with ciprofloxacin (Unni et al., 2001 and Corstens et al., 1999) , as well as Tc-UBI 29-41 (Hall et al., 1998) , for diagnostic purposes (SPECT). Radiotherapy can be directed by diagnostic SPECT or PET (diagnostic imaging), which are merged into theranostics approaches for the diagnosis and treatment of a variety of tumor types that are rapidly gaining momentum, for example, 177 Lu-labeled sulfadiazine used as a possible theranostic agent for deep-seated bacterial infection (Naqvi1 et al., 2017) . 186 Re is an ideal candidate for radioimmunotherapy, especially in bone pain palliation (Kinuya et al., 2003 , 2005 and Postema et al., 2003 , due to its short range β¯emission (< 2mm in tissue) with energies at 1.07 and 0.933MeV (71 and 22%, respectively), low-abundance (9%) γ-ray emission at 137keV, which allows for invivo tracking of the radiolabeled biomolecules and the estimation of dosimetry calculation. The suitable half-life (3.7-day) allows sufficient time for the synthesis, shipment of potential radiopharmaceuticals and the radiotherapy. It can be produced by different ways, the dominant routes are; nuclear reactor through (n, γ) reaction and cyclotron through 186 W(p,n) 186 Re reaction. The principal drawback of the former reaction is that the radionuclide 186 Re is produced as a carrier added form with a low specific activity, whereas the latter is better due to its carrier-free nature and also for high specific activity that is generally required for the radiolabeling of tumor-specific antibodies (Volkert et al., 1991) .
Cephalosporins are antibiotics of β-lactam rings widely used for the therapy of various infections in both humans and animals due to their antibacterial and pharmacokinetic properties. They are among the safest antibiotics to be active against penicillin-resistant bacteria and being feasible for penicillin-allergic patients. Cefxime (CEF) is a semisynthetic third-generation oral antibiotic belonging to the cephalosporin group and works by inhibiting bacterial cell wall synthesis. Hence, cefixime belongs to a class of medications called cephalosporin antibiotics. Its bactericidal action is mainly due to the inhibition of the final transpeptidation step of the peptidoglycan synthesis in the bacterial cell wall, thus inhibiting cell wall assembly resulting in bacterial cell death (Graham, 2005) . Thermal stability of Cefixime was studied and confirmed its stability up to 80°C for about 3hr (Dhara et al., 2017 Re-Cefixime in the distinction between septic and aseptic inflammation and pointing out its importance as a radiotherapy.
Experimental

Materials and instruments
All reagents used in the present work were of analytical grade. Re /mg Re (~86.3 MBq/mg).
Radiochemical purity of rhenium-186
Whatman paper No.3 as a stationary phase and acetone as a development medium were used. Figure 1 shows that the retardation factor (R f ) was obtained at 0.9-1, which corresponds to the perrhenate form ( 186 ReO 4 -) (Nomando, 2001 and Eckelman & Levenson, 1977) .
Affecting factors on the RCY of 186
Re-Cefixime The RCY of 
Biodistribution
Injection of the 186
Re-cefixime tracer 186
Re-Cefixime (100µL, 2.5-3MBq) was injected intravenously (I.V.) into the tail vein of the mice. Groups of four mice were used for each experiment. The mice were sacrificed by the decapitation under chloroform anesthesia at 15, 60, 120 and 240min post injection. Blood samples were collected at the time of decapitation. Both thighs (the right thigh muscle as a target and the left thigh muscle as a control), all body organs were dissected, weighed and counted their radioactivity using a well-type NaI(Tl) detector connected with a single channel γ-counter (SR-7). Results were expressed as percent of the injected dose per organ or body fluid. Bone, blood and muscles were calculated as 10, 7, and 40% of the total body weight, respectively (Korde et al., 1998) . The uptake of
186
Re-Cefixime in muscles or organs was calculated as a percentage of the injected dose per 1g of the body weight.
Bacterial infection and Sterile Inflammation
Infections were introduced by injection of 2x 10 6 by E. Coli (Sakr, 2010; Johannsen & Spies, 1991 and El-Ghany et al., 2005) , suspended in 0.1ml saline into the right thigh muscle. Five days later, the growth appeared. Sterile inflammation was induced by the intramuscular injection of the autoclaved turpentine oil into the right thigh muscle 0.1ml/mice. Six days later, the growth appeared. Target to non-target (T/NT) ratio was calculated at different interval times for the uptake of Recefixime to distinguish between the different types of inflammations.
Results and Discussion
Effect of cefixime amount
The RCY of 186
Re-cefixime as a function of cefixime concentration in the presence of stannous chloride dihydrate as a reducing agent was studied as shown in Fig. 3 . The results reveal that the RCY of 186 Re-cefixime increased from 85±1.7 to 96±2.8% by increasing the amounts of cefixime from 0.5 to 5mg. An increasing cefixime amount more than 2mg does not affect the RCY of 186 Recefixime while, less than this amount leads to decreasing the RCY that may be attributed to the fact that the concentration of cefixime is insufficient to shift completes the complex formation towards the final complex (Amin et al., 2009 The reaction mixture (10μL) was placed 12cm away from the cathode. Normal saline solution (0.9% w/v NaCl solution) was used as an electrolyte solution and then the electrophoretic paper was run out for 1.5h at 300V. After that, the paper was removed, dried, cut into segments of 1cm, and counted in a well-type γ-counter. The radiochemical yield was determined by the following equation:
Radiochemical yield (%)= Re-Cefixime towards the anode at 7 and 4cm, respectively, as shown in Fig. 2 . 
HPLC analysis
The radiochemical purity and chemical stability of 186 Re-Cefixime were determined by its injection (5-10μl) to HPLC. A reversed phase column-18 (250mm × 4.6 mm, 5μm) as a stationary phase, methanol: H 2 O (70: 30 v/v) as a mobile phase at a flow rate of 1ml/min, and UV region (at the wavelength 254nm), were used for the determination of Cefixime and perrhenate (ReO 4 -). The radioactivity of 186 Re-Cefixime was determined by using a well-type NaI (Tl) crystal connected to single channel analyzer. 
Effect of stannous chloride dihydrate amount
The amount of stannous chloride on the RCY of ReCefixime decreased in the low amount of SnCl 2 that may be attributed to its insufficient concentration to reduce the rhenium (VII) (ReO 4 -) to lower oxidation states (El-Kawy & Talaat, 2016) . While most of the ligand molecule was consumed in the formation of complex, the perhenate is reduced to insoluble rhenium (IV) ReO 2 .xH 2 O in the absence of ligand at the high concentration of stannous chloride (Azmi et al., 2013) . Moreover, at a high concentration of Sn(II), the reduction reaction rate increases to form a colloid so that it becomes more competitive with respect to the complexation reaction, thus decreasing the RCY of 186 Re-cefixime. Figure 5 shows the obtained results by the preparation of Re-cefixime at different values of pH. The RCY decreased to 75±1.5 % at pH 2 that may be attributed to the protonation of Cefixime, and this may lead to decreasing the stability of the 186 Re-Cefixime complex. Increasing the pH from 2 to 5.5 increases the RCY from 75±1.5 to 96±2.8%, this may be attributed to the deprotonation of cefixime and may increase 
Effect of pH of the reaction mixture
Effect of reaction temperature
The maximum RCY of Re-cefixime (96±2.8%) was obtained at the room temperature -up to 40 o C, then the RCY decreased to 87±2.1, 75±1.5 and 65±1.2% by increasing the reaction temperature to 60, 80 and 100 O C, respectively, as shown in Fig. 6 . The results showed that the room temperature represents the optimum temperature used in the preparation of 186 Re-cefixime complex. The RCY of 186 Re-cefixime decreased by increasing the temperature, this may be due to the fact that the temperature disintegrates the 186 Re-cefixime complex, but it does not affect the cefixime as a compound. This explanation is more realistic because the literature data confirmed the thermal stability of cefixime up to 80 o C (Dhara al., 2017) . 
Effect on reaction time
The effect of reaction time on the RCY of 186
ReCefixime was shown in Fig. 7 . The RCY of 186 ReCefixime increased from 79±1.6 to 96±2.8% and reached an equilibrium by increasing the reaction time from 10 to 30min at room temperature. The 186 Re-cefixime was stable for up to 4hr. 
Reaction mechanism
The maximum RCY of moles) at room temperature and pH 5.5 within 30min. The reactions were carried out depending on the molar ratio 2: 1: 1 of Cefixime: Rhenium: Stannous, as in equations 1-3 and based on the active groups, which has been used to form Pd(II)-cefixime complex (Azmi et al., 2013 Re-Cefixime are stable due to the absence of any peaks that resulted from the decomposition of Cefixime or 186 Re-Cefixime. The literature data show the decomposition of Cefixime using the C18 column at 254nm (Adam et al., 2011) . The RCY of 186 Re-Cefixime reached the equilibrium state within 30min and its chemical stability lasts up to 240min (Fig. 7) .
Biodistribution studies
In many cases, there is a difficulty in discriminating between sterile inflammation (aseptic) as in head traumas, accidental traumas, joint, bone or muscle and bacterial inflammation (septic), so the sequence of treatment may not be started well. Hence, the patient may receiveuseless drugs. SPECT radio-pharmaceutics could be used to distinguish between both cases and so serve patients and medications. Many trials were performed using several labeled compounds such as ciprofloxacin, norfloxacin, ceftriaxone and others (Zolle, 2007 and El-Ghany et al., 2005) . Re-cefixime (12.2% at 120min post-injection) was due to the high blood vasculature and the lipophilicity of the tracer. The radioactivity located in the kidney increased from 12.4 to 20.2% by increasing the time from 60 to 120min post-injection. The uptake of 186 Recefixime in the corresponding organs (non-targets) of the studied mice (normal, steril infection and bacterial infections) are much closer to each other, such as the uptake of the stomach which was 3.7, 3.9 and 3.1%, respectively at 120min postinjection.Whereas a variation between the muscles uptake (target) (1.1, 1.8 and 6.2%, respectively at 120min post-injection) was observed. The
In normal mice
186
Recefixime was removed from the circulation mainly via the kidney and liver with an average 20 and 13%, respectively.
In sterile inflamed mice
The bio-distribution of 186 Re-cefixime in sterile inflamed muscle in Table 2 shows a slight difference compared to that in the control mice. The 186 Re-cefixime uptake increased in the sterile inflamed muscle compared to the muscle control that may be attributed to the high vascularity leading to the vasodilatation (inflammation site) and hence a high blood flow in this site (nonspecific uptake). This is also clear from T/NT in Table 2 . Sterile inflammation sites are rich with a Cyclooxygenase enzyme (CoX 1, 2 ) which makes orientation to drugs inhibit (CoX 1, 2 ) as analgesics or anti-inflammatories not antibiotics as cefixime (Yoshimi et al., 1997) . Table 3 shows the ratio of target to non-target (T/NT). The T/NT ratios of the sterile infected muscle differ from the bacterially infected muscle at all times recorded (15, 50, 120 and 240min) . The maximum ratio of T/NT (3.9) was obtained at 120min post-injection for the bacterially infected muscle. Figure 9 demonstrates that the accumulated activity of 186 Re-cefixime in bacterially infected muscle was fourfold the control muscle at 120min. All data supported the location of 186 Re-cefixime in the infected muscle due to bacteria.
In infected mice
In vivo stability of 186
Re-Cefixime The 186
Re-Cefixime was injected and studied in mice at different time intervals (15, 60, 120 and 240min) . The results confirmed that the compound achieved the desired goal, its concentration in the infected muscle due to bacterial orientation ( Tables  1-3 Re-cefixime radiotracer is suggested to be used as a diagnostic and therapeutic agent to the bacterial infection due to the fact that 186 Re has a short range β¯emission (< 2mm in tissue) with energies at 1.07 and 0.933MeV (71 and 22%, respectively), low-abundance γ-ray emission (9%) at 137keV and its suitable half-life (3.7-day). 
